Produkt verwendet in:
Kato, Iwama, Yamashita, Kobayashi, Fujihara, Fujimori, Kamada, Kobara, Masaki: "The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin." in: Oncology reports, Vol. 35, Issue 3, pp. 1582-92, 2016 (PubMed).
(Probematerial (Species): Human). Weitere Details: Sample: Tissue Lysate (Pancreatic cancer cell lines, PK9, PANC1, PK1)
Rios-Doria, Sabol, Chesebrough, Stewart, Xu, Tammali, Cheng, Du, Schifferli, Rothstein, Leow, Heidbrink-Thompson, Jin, Gao, Friedman, Wilkinson, Damschroder, Pierce, Hollingsworth, Tice, Michelotti: "A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways." in: Molecular cancer therapeutics, Vol. 14, Issue 7, pp. 1637-49, 2015 (PubMed).
(Probematerial (Species): Human). Weitere Details: Sample: Tissue Lysate (Human tumor cells xenograft models)
Arnold, Abdelmoez, Thurner, Debbage, Lukas, Skvortsov, Skvortsova: "Rac1 as a multifunctional therapeutic target to prevent and combat cancer metastasis." in: Oncoscience, Vol. 1, Issue 8, pp. 513-21, 2015 (PubMed).
Montermini, Meehan, Garnier, Lee, Lee, Guha, Al-Nedawi, Rak: "Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content." in: The Journal of biological chemistry, Vol. 290, Issue 40, pp. 24534-46, 2015 (PubMed).
Panupinthu, Yu, Zhang, Zhang, Gagea, Lu, Grandis, Dunn, Lee, Mills: "Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer." in: Oncogene, Vol. 33, Issue 22, pp. 2846-56, 2014 (PubMed).
Siu, Ruzevick, Zhao, Connis, Jiao, Bettegowda, Xia, Burger, Hann, Gallia: "Erlotinib inhibits growth of a patient-derived chordoma xenograft." in: PLoS ONE, Vol. 8, Issue 11, pp. e78895, 2014 (PubMed).
Slanina, Mündlein, Hebling, Schubert-Unkmeir: "Role of epidermal growth factor receptor signaling in the interaction of Neisseria meningitidis with endothelial cells." in: Infection and immunity, Vol. 82, Issue 3, pp. 1243-55, 2014 (PubMed).
Cheng, Wong, Alston, Mackenzie, Huang, Ouyang, Xie, Wiedmann, Rigas: "Aerosol administration of phospho-sulindac inhibits lung tumorigenesis." in: Molecular cancer therapeutics, Vol. 12, Issue 8, pp. 1417-28, 2013 (PubMed).
Kesanakurti, Chetty, Rajasekhar Maddirela, Gujrati, Rao: "Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma." in: Cell death & disease, Vol. 3, pp. e445, 2013 (PubMed).
Zhu, Belkhiri, El-Rifai: "DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib." in: Gastroenterology, Vol. 141, Issue 5, pp. 1738-48.e1-2, 2011 (PubMed).
Godek, Sargiannidou, Patel, Hurd, Rothman, Tuszynski: "Angiocidin inhibits breast cancer proliferation through activation of epidermal growth factor receptor and nuclear factor kappa (NF-ĸB)." in: Experimental and molecular pathology, Vol. 90, Issue 3, pp. 244-51, 2011 (PubMed).
Shalaby, Presneau, Ye, Halai, Berisha, Idowu, Leithner, Liegl, Briggs, Bacsi, Kindblom, Athanasou, Amary, Hogendoorn, Tirabosco, Flanagan: "The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target." in: The Journal of pathology, Vol. 223, Issue 3, pp. 336-46, 2010 (PubMed).
Park, Tan, Datta, Lai, Zhang, Meng, Lim, Sze: "Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes." in: Molecular & cellular proteomics : MCP, Vol. 9, Issue 6, pp. 1085-99, 2010 (PubMed).
Zhang, Ji, Yu, Overholtzer, Smolen, Wang, Brugge, Dyson, Haber: "YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway." in: Nature cell biology, Vol. 11, Issue 12, pp. 1444-50, 2009 (PubMed).
Bhuvaneswari, Gan, Soo, Olivo: "Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response." in: Molecular cancer, Vol. 8, pp. 94, 2009 (PubMed).